EBOVAC2 | Development of a Prophylactic Ebola Vaccine Using an Heterologous Prime-Boost Regimen: Phase II - Sofia ref.: 115861 01-12-2014 - 31-05-2021 Show more information EU-Programme-Call Horizon 2020 H2020-EU.3. SOCIETAL CHALLENGES H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being H2020-EU.3.1.7. Innovative Medicines Initiative 2 (IMI2) H2020-EU.3.1.7.0. Cross-cutting call topics H2020-JTI-IMI2-2014-02-single-stage IMI2-2014-02-01 Vaccine development Phase I, II, and III
EBOVAC1 | Development of a Prophylactic Ebola Vaccine Using an Heterologous Prime-Boost Regimen – Sofia ref.: 115854 01-12-2014 - 30-11-2021 Show more information EU-Programme-Call Horizon 2020 H2020-EU.3. SOCIETAL CHALLENGES H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being H2020-EU.3.1.7. Innovative Medicines Initiative 2 (IMI2) H2020-EU.3.1.7.0. Cross-cutting call topics H2020-JTI-IMI2-2014-02-single-stage IMI2-2014-02-01 Vaccine development Phase I, II, and III
VSV-EBOVAC | Vaccine safety and immunogenicity signatures of human responses to VSV-ZEBOV – Sofia ref.: 115842 01-03-2015 - 28-02-2019 Show more information EU-Programme-Call Horizon 2020 H2020-EU.3. SOCIETAL CHALLENGES H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being H2020-EU.3.1.7. Innovative Medicines Initiative 2 (IMI2) H2020-EU.3.1.7.0. Cross-cutting call topics H2020-JTI-IMI2-2014-02-single-stage IMI2-2014-02-01 Vaccine development Phase I, II, and III